HomeQuestion

Is there a role for pharmacologic or exercise stress testing for patients with recurrent syncope of unclear etiology?

Join the Discussion

Discuss the cases and questions guidelines don't cover.

Related Questions

What are your thoughts on the results from the AQUATIC trial which showed that the addition of aspirin daily + oral anticoagulation in patients > 6 months from PCI and with high atherothrombotic risk was associated with a higher risk of death, MI, stroke, coronary revascularization and acute limb ischemia, compared to oral anticoagulation alone?

What are your preferred lipid-lowering agents and target LDL reduction goal following initiation of therapy for patients with familial hyperlipidemia without underlying CAD?

How should a CAC score of 350 influence risk stratification in an asymptomatic primary‑prevention patient with borderline‑to‑intermediate ASCVD risk?

What are your top takeaways for the 2026 ACC/AHA lipid guidelines?

When would you consider starting lipid-lowering therapy for young adults < 30 years of age who have markedly elevated LP(a) and family history of elevated LP(a) and ischemic heart disease?

Evidence Meets Expertise

For Physicians

Mednet AI
Community

Company

About
Careers
Publications
Blog

Support

FAQs
Code of Conduct
AI Community Guidelines
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.